FIELD: medicine; pharmaceuticals.
SUBSTANCE: combined soft dosage form containing a therapeutically effective amount of diosmin and troxerutin. Dosage form includes auxiliary substances and a system of preserving agents containing paraben in a concentration sufficient for creation and maintenance of the preservative effectiveness, differing by the fact that the pH of the given combined soft dosage form is within 5.0 to 7.0.
EFFECT: dosage form is convenient to use and is stable during prolonged storage at temperature less than +25 °C.
1 cl, 4 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHLEBOTROPHIC COMBINATION PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2704976C2 |
| COMBINED SOFT DOSAGE FORM FOR TREATING HAEMORRHOID DISEASES | 2018 |
|
RU2705794C1 |
| STABLE SOFT DOSAGE FORM OF DIOXIDINE | 2020 |
|
RU2741787C1 |
| TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
| PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE CONTAINING A SALT OF DEXKETOPROFEN, AND A PROCESS FOR ITS PREPARATION | 2015 |
|
RU2667465C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VEIN DISEASES AND METHOD FOR ITS PREPARING | 2005 |
|
RU2299070C2 |
| LIQUID MEDICINAL FORM RISPERIDONE AND METHOD FOR ITS MANUFACTURE | 2016 |
|
RU2646812C1 |
| STABLE PHARMACEUTICAL COMPOSITION LAMIVUDINE | 2015 |
|
RU2587782C1 |
| STABILISED PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES CAUSED BY VENOUS INSUFFICIENCY | 2011 |
|
RU2458694C1 |
| LIQUID DOSAGE FORM OF FENSPIRIDE AND PRODUCTION METHOD THEREOF | 2015 |
|
RU2607965C1 |
